Get in Touch



SL-1361

(S)-Crizotinib, 98%

CAS No. : 
[1374356-45-2]    
MDL No. : 
MFCD22126092
Synonyms : 3-[(1S)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
10MG120.00 Back Order Estimated to Ship on 01.20.2025
25MG250.00 Back Order Estimated to Ship on 01.20.2025
50MG450.00 Back Order Estimated to Ship on 01.20.2025
100MG850.00 Back Order Estimated to Ship on 01.20.2025
250MG1950.00 Back Order Estimated to Ship on 01.20.2025
Chemical Properties
C21H22Cl2FN5O 450.34
Solid Not available
For Laboratory research use only, not for drug, household or other uses.
Applications : (S)-Crizotinib, the (S)-enantiomer of crizotinib, is a potent MTH1 (NUDT1) inhibitor with IC50 of 72 nM in a cell-free assay. (S)-Crizotinib can also serve as a promising anticancer agent.
References : Huber. K.V.M. et al.: Nature, 508, 222, 2014.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-1361

Product Name : (S)-Crizotinib

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!